Selective recovery of striatal 125I-α-conotoxinmii nicotinic receptors after nigrostriatal damage in monkeys

Neuroscience

Volumn 127, Issue 2, 2004, Pages 399-408

  Lai, A ^a   Sum, J ^a   Fan, H ^b   McIntosh, J M ^c   Quik, M ^a  

^a PARKINSON S INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

conotoxinMII; CtxMII; 1,2,di 2 aminoethoxyethane NNN N tetraacetic acid; A85380; bovine serum albumin; BSA; EDTA; EGTA; epibatidine; ethylenediaminetetraacetic acid; MPTP; nigrostriatal; Parkinson

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 (2 AZETIDINYLMETHOXY)PYRIDINE; CONOTOXIN; DOPAMINE TRANSPORTER; EPIBATIDINE; IODINE 125; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DRUG INDUCED DISEASE; EXPERIMENTAL MODEL; GENERAL CONDITION IMPROVEMENT; MOUSE; NONHUMAN; PARKINSON DISEASE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR SENSITIVITY; SCORING SYSTEM; SQUIRREL MONKEY; STRIATE CORTEX; STRIATONIGRAL DEGENERATION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; AZETIDINES; BICYCLO COMPOUNDS, HETEROCYCLIC; CONOTOXINS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; IODINE RADIOISOTOPES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NEURAL PATHWAYS; PARKINSONIAN DISORDERS; PRESYNAPTIC TERMINALS; PYRIDINES; RECEPTORS, NICOTINIC; RECOVERY OF FUNCTION; SAIMIRI; SUBSTANTIA NIGRA; UP-REGULATION;

EID: 3242688047     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.04.059     Document Type: Article

References (33)

1. Cartier G.E., Yoshikami D., Gray W.R., Luo S., Olivera B.M., McIntosh J.M. A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J Biol Chem. 271:1996;7522-7528
2. Champtiaux N., Han Z.Y., Bessis A., Rossi F.M., Zoli M., Marubio L., McIntosh J.M., Changeux J.P. Distribution and pharmacology of α6-containing nicotinic acetylcholine receptors analyzed with mutant mice. J Neurosci. 22:2002;1208-1217
3. Champtiaux N., Gotti C., Cordero-Erausquin M., David D.J., Przybylski C., Lena C., Clementi F., Moretti M., Rossi F.M., Le Novere N., McIntosh J.M., Gardier A.M., Changeux J.P. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J Neurosci. 23:2003;7820-7829
4. Charpantier E., Barneoud P., Moser P., Besnard F., Sgard F. Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area. Neuroreport. 9:1998;3097-3101
5. Clarke P.B., Pert A. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res. 348:1985;355-358
6. Dauer W., Przedborski S. Parkinson's disease Mechanisms and models. Neuron. 39:2003;889-909
7. 125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors. J Pharmacol Exp Ther. 282:1997;445-451
8. Di Monte D.A. The environment and Parkinson's disease Is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurol. 2:2003;531-538
9. Elliott K.J., Jones J.M., Sacaan A.I., Lloyd G.K., Corey-Naeve J. 6-Hydroxydopamine lesion of rat nigrostriatal dopaminergic neurons differentially affects nicotinic acetylcholine receptor subunit mRNA expression. J Mol Neurosci. 10:1998;251-260
10. Elsworth J.D., Taylor J.R., Sladek J.R. Jr, Collier T.J., Redmond D.E. Jr, Roth R.H. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neuroscience. 95:2000;399-408
11. Emmers R., Akert K. A stereotaxic atlas of the brain of the squirrel monkey ( Saimiri sciureus). 1963;University of Wisconsin Press, Madison
12. Franklin K.B.J., Paxinos G. The mouse brain in stereotaxic coordinates. 1997;Academic Press, San Diego
13. 3H]dopamine release from synaptosomes prepared from mouse striatum. J Neurochem. 59:1992;848-856
14. Ingham C.A., Hood S.H., Taggart P., Arbuthnott G.W. Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J Neurosci. 18:1998;4732-4743
15. 3H]dopamine release in rat striatal slices via glutamate release. Mol Pharmacol. 58:2000;312-318
16. Kulak J.M., McIntosh J.M., Quik M. Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in α-conotoxin MII sites. Mol Pharmacol. 61:2002;230-238
17. Kulak J.M., Musachio J.L., McIntosh J.M., Quik M. Declines in different β2* nicotinic receptor populations in monkey striatum after nigrostriatal damage. J Pharmacol Exp Ther. 303:2002;633-639
18. Langston J.W., Quik M., Petzinger G., Jakowec M., Di Monte D.A. Investigating levodopa-induced dyskinesias in the parkinsonian primate. Ann Neurol. 47:2000;S79-S89
19. Marchi M., Risso F., Viola C., Cavazzani P., Raiteri M. Direct evidence that release-stimulating α7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals. J Neurochem. 80:2002;1071-1078
20. Mukhin A.G., Gundisch D., Horti A.G., Koren A.O., Tamagnan G., Kimes A.S., Chambers J., Vaupel D.B., King S.L., Picciotto M.R., Innis R.B., London E. 5-Iodo-A-85380, an α4β2 subtype-selective ligand for nicotinic acetylcholine receptors. Mol Pharmacol. 57:2000;642-649
21. Musachio J.L., Villemagne V.L., Scheffel U.A., Dannals R.F., Dogan A.S., Yokoi F., Wong D.F. Synthesis of an I-123 analog of A-85380 and preliminary SPECT imaging of nicotinic receptors in baboon. Nucl Med Biol. 26:1999;201-207
22. 3H]epibatidine labels nicotinic receptors in rat brain An autoradiographic study. J Pharmacol Exp Ther. 275:1995;1030-1034
23. Quik M., Kulak J.M. Nicotine and nicotinic receptors Relevance to parkinson's disease. Neurotoxicology. 23:2002;581-594
24. 125I-α-conotoxin MII binding sites to nigrostriatal damage in monkey. J Neurosci. 21:2001;5494-5500
25. Quik M., Polonskaya Y., Gillespie A., Lloyd G., Langston J.W. Differential alterations in nicotinic receptor α6 and β3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration. Neuroscience. 100:2000;63-72
26. Quik M., Sum J.D., Whiteaker P., McCallum S.E., Marks M.J., Musachio J., McIntosh J.M., Collins A.C., Grady S.R. Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice. Mol Pharmacol. 63:2003;1169-1179
27. 3H]acetylcholine on catecholamine and serotonin axons in brain. J Neurochem. 42:1984;1495-1498
28. Song D.D., Haber S.N. Striatal responses to partial dopaminergic lesion Evidence for compensatory sprouting. J Neurosci. 20:2000;5102-5114
29. Stanic D., Finkelstein D.I., Bourke D.W., Drago J., Horne M.K. Timecourse of striatal re-innervation following lesions of dopaminergic SNpc neurons of the rat. Eur J Neurosci. 18:2003;1175-1188
30. Stanic D., Parish C.L., Zhu W.M., Krstew E.V., Lawrence A.J., Drago J., Finkelstein D.I., Horne M.K. Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpc. J Neurochem. 86:2003;329-343
31. 125I-α-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain. Mol Pharmacol. 57:2000;913-925
32. Whiteaker P., Peterson C.G., Xu W., McIntosh J.M., Paylor R., Beaudet A.L., Collins A.C., Marks M.J. Involvement of the α3 subunit in central nicotinic binding populations. J Neurosci. 22:2002;2522-2529
33. Zoli M., Moretti M., Zanardi A., McIntosh J.M., Clementi F., Gotti C. Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J Neurosci. 22:2002;8785-8789